Upgrade to SI Premium - Free Trial

Truist Securities Starts Altimmune (ALT) at Buy

March 18, 2026 3:53 PM
(Updated - March 18, 2026 3:53 PM EDT)

Truist Securities analyst Srikripa Devarakonda initiates coverage on Altimmune (NASDAQ: ALT) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage